MetaADEDB 2.0 @ LMMD
bosutinib
(UBPYILGKFZZVDX-UHFFFAOYSA-N)
Structure
SMILES
COc1cc2c(cc1OCCCN1CCN(CC1)C)ncc(c2Nc1cc(OC)c(cc1Cl)Cl)C#N
Type(s)
Approved
ATC code(s)
L01XE14
Molecular Formula:
C26H29Cl2N5O3
Molecular Weight:
530.446
Log P:
5.1392
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
82.88
CAS Number(s):
380843-75-4; 1391063-17-4
Synonym(s)
1.
bosutinib
2.
SKI-606
3.
SKI606
External Link(s)
MeSHC471992
PubChem Compound5328940
BindingDB4552
ChEBI39112
CHEMBLCHEMBL288441
DrugBankDB06616
DrugCentral4359
IUPHAR/BPS Guide to PHARMACOLOGY5710
KEGGdr:D03252
Therapeutic Target DatabaseD0OB0F
ZINC22448983
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 384
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
2FatigueFAERS: 229
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
3VomitingFAERS: 185
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
4HeadacheFAERS: 112SIDER
US FAERS
5MalaiseFAERS: 91SIDER
US FAERS
6Abdominal PainFAERS: 71SIDER
US FAERS
7DizzinessFAERS: 65SIDER
US FAERS
8PainFAERS: 65
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
9ConstipationFAERS: 62US FAERS
10ArthralgiaFAERS: 61SIDER
US FAERS
11Disease ProgressionFAERS: 57US FAERS
12Abdominal discomfortFAERS: 55SIDER
US FAERS
13AstheniaFAERS: 55SIDER
US FAERS
14PneumoniaFAERS: 53
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
15Weight decreasedFAERS: 49US FAERS
16PruritusFAERS: 44SIDER
US FAERS
17DehydrationFAERS: 32
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
18MyalgiaFAERS: 32SIDER
US FAERS
19White blood cell count decreasedFAERS: 29US FAERS
20Chest PainFAERS: 28SIDER
US FAERS
21Drug dose omissionFAERS: 28US FAERS
22DyspepsiaFAERS: 27US FAERS
23Bone painFAERS: 26US FAERS
24Feeling abnormalFAERS: 25
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
25Peripheral swellingFAERS: 25US FAERS
26DysgeusiaFAERS: 24SIDER
US FAERS
27FlatulenceFAERS: 22US FAERS
28NasopharyngitisFAERS: 22SIDER
US FAERS
29Back PainFAERS: 21SIDER
US FAERS
30Cerebrovascular accidentFAERS: 20US FAERS
31Intentional product misuseFAERS: 20US FAERS
32Blood creatinine increasedFAERS: 19SIDER
US FAERS
33Product use issueFAERS: 19US FAERS
34ThrombocytopeniaFAERS: 19
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
35Alanine Aminotransferase IncreasedFAERS: 18
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
36HypersensitivityFAERS: 17US FAERS
37InfluenzaFAERS: 17SIDER
US FAERS
38Dry skinFAERS: 16US FAERS
39InfectionFAERS: 16SIDER
US FAERS
40Memory impairmentFAERS: 16US FAERS
41Pericardial effusionFAERS: 15
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
42Product use in unapproved indicationFAERS: 15US FAERS
43Atrial FibrillationFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
44ChillsFAERS: 14US FAERS
45Product dose omissionFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
46AlopeciaFAERS: 13US FAERS
47AnxietyFAERS: 13US FAERS
48SinusitisFAERS: 13US FAERS
49UrticariaFAERS: 13SIDER
US FAERS
50SomnolenceFAERS: 12US FAERS
51Therapy cessationFAERS: 12US FAERS
52Gastric ulcerFAERS: 11US FAERS
53Joint swellingFAERS: 11US FAERS
54Myocardial InfarctionFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
55PancreatitisFAERS: 11US FAERS
56SneezingFAERS: 11US FAERS
57Lip swellingFAERS: 10US FAERS
58Aspartate Aminotransferase IncreasedFAERS: 9SIDER
US FAERS
59Blood glucose increasedFAERS: 9US FAERS
60CytopeniaFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
61DysphoniaFAERS: 9US FAERS
62HypotensionFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
63AcneFAERS: 8SIDER
US FAERS
64Chest discomfortFAERS: 8
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
65EpistaxisFAERS: 8US FAERS
66HepatotoxicityFAERS: 8SIDER
US FAERS
67No adverse eventFAERS: 8US FAERS
68Oropharyngeal painFAERS: 8US FAERS
69Transaminases increasedFAERS: 8US FAERS
70Angina PectorisFAERS: 7US FAERS
71BlindnessFAERS: 7US FAERS
72Blood iron decreasedFAERS: 7US FAERS
73BronchitisFAERS: 7SIDER
US FAERS
74CellulitisFAERS: 7US FAERS
75CholelithiasisFAERS: 7US FAERS
76Gait inabilityFAERS: 7US FAERS
77Loss of personal independence in daily activitiesFAERS: 7US FAERS
78NeutropeniaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
79PancytopeniaFAERS: 7SIDER
US FAERS
80Respiratory FailureFAERS: 7SIDER
US FAERS
81UlcerFAERS: 7US FAERS
82Urinary tract infectionFAERS: 7US FAERS
83VertigoFAERS: 7US FAERS
84AngioedemaFAERS: 6US FAERS
85Blood count abnormalFAERS: 6US FAERS
86Blood pressure fluctuationFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
87Burning sensationFAERS: 6US FAERS
88Disease recurrenceFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
89ErythemaFAERS: 6US FAERS
90GoutFAERS: 6US FAERS
91Rash erythematousFAERS: 6US FAERS
92SciaticaFAERS: 6US FAERS
93SwellingFAERS: 6US FAERS
94Toxicity to various agentsFAERS: 6US FAERS
95Visual ImpairmentFAERS: 6US FAERS
96Acute kidney injuryFAERS: 5US FAERS
97AgeusiaFAERS: 5US FAERS
98AsthmaFAERS: 5US FAERS
99Cerebral InfarctionFAERS: 5US FAERS
100DeafnessFAERS: 5US FAERS
101Diabetes MellitusFAERS: 5US FAERS
102DysuriaFAERS: 5US FAERS
103Feeling ColdFAERS: 5US FAERS
104Full blood count decreasedFAERS: 5US FAERS
105General physical health deteriorationFAERS: 5US FAERS
106Pain of skinFAERS: 5US FAERS
107Poor quality sleepFAERS: 5US FAERS
108Rheumatoid ArthritisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
109Skin WrinklingFAERS: 5US FAERS
110Throat irritationFAERS: 5US FAERS
111White blood cell count abnormalFAERS: 5US FAERS
112Acute myocardial infarctionFAERS: 4US FAERS
113AmnesiaFAERS: 4US FAERS
114ArthropathyFAERS: 4US FAERS
115Blood urine presentFAERS: 4US FAERS
116Body temperature fluctuationFAERS: 4US FAERS
117Cardiac TamponadeFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
118ChromaturiaFAERS: 4US FAERS
119Clostridium difficile infectionFAERS: 4US FAERS
120DiscomfortFAERS: 4
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
121DiverticulitisFAERS: 4US FAERS
122Drug ineffectiveFAERS: 4US FAERS
123Electrolyte imbalanceFAERS: 4US FAERS
124Expired product administeredFAERS: 4US FAERS
125Eye painFAERS: 4US FAERS
126Fluid overloadFAERS: 4US FAERS
127FractureFAERS: 4US FAERS
128GastroenteritisFAERS: 4US FAERS
129Gastrointestinal infectionFAERS: 4US FAERS
130HaematotoxicityFAERS: 4US FAERS
131Head discomfortFAERS: 4US FAERS
132Intentional product use issueFAERS: 4US FAERS
133Intervertebral disc disorderFAERS: 4US FAERS
134LethargyFAERS: 4US FAERS
135Lipase increasedFAERS: 4SIDER
US FAERS
136Muscle tightnessFAERS: 4US FAERS
137Musculoskeletal PainFAERS: 4US FAERS
138Neck PainFAERS: 4US FAERS
139Paranasal sinus hypersecretionFAERS: 4US FAERS
140PericarditisFAERS: 4
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
141PhotophobiaFAERS: 4US FAERS
142PneumonitisFAERS: 4US FAERS
143Productive CoughFAERS: 4US FAERS
144Protein total increasedFAERS: 4US FAERS
145Pulmonary HypertensionFAERS: 4SIDER
US FAERS
146Red cell distribution width decreasedFAERS: 4US FAERS
147Renal painFAERS: 4US FAERS
148SepsisFAERS: 4US FAERS
149SnoringFAERS: 4US FAERS
150StomatitisFAERS: 4US FAERS
151Altered state of consciousnessFAERS: 3US FAERS
152Amylase increasedFAERS: 3SIDER
US FAERS
153ArthritisFAERS: 3US FAERS
154Blood potassium decreasedFAERS: 3US FAERS
155ChylothoraxFAERS: 3US FAERS
156Cytogenetic analysis abnormalFAERS: 3US FAERS
157Erectile dysfunctionFAERS: 3US FAERS
158EructationFAERS: 3US FAERS
159FlushingFAERS: 3US FAERS
160Gamma-Glutamyltransferase IncreasedFAERS: 3SIDER
US FAERS
161HypersomniaFAERS: 3US FAERS
162LeukocytosisFAERS: 3US FAERS
163Limb discomfortFAERS: 3US FAERS
164Lung consolidationFAERS: 3US FAERS
165Musculoskeletal stiffnessFAERS: 3US FAERS
166Night sweatsFAERS: 3US FAERS
167NocturiaFAERS: 3US FAERS
168NoduleFAERS: 3US FAERS
169Occult blood positiveFAERS: 3US FAERS
170Oral painFAERS: 3US FAERS
171PalpitationsFAERS: 3US FAERS
172Product size issueFAERS: 3US FAERS
173Pulmonary EmbolismFAERS: 3US FAERS
174Skin lesionFAERS: 3US FAERS
175ThrombosisFAERS: 3US FAERS
176Wrong technique in product usage processFAERS: 3US FAERS
177AbasiaFAERS: 2US FAERS
178Accidental overdoseFAERS: 2US FAERS
179AngerFAERS: 2US FAERS
180AnosmiaFAERS: 2US FAERS
181ApathyFAERS: 2US FAERS
182AppendicitisFAERS: 2US FAERS
183AtelectasisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
184Autoimmune thyroiditisFAERS: 2US FAERS
185Blood creatine phosphokinase increasedFAERS: 2SIDER
US FAERS
186Blood magnesium abnormalFAERS: 2US FAERS
187Blood phosphorus abnormalFAERS: 2US FAERS
188Blood sodium decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
189BradycardiaFAERS: 2US FAERS
190Cardiac ArrestFAERS: 2US FAERS
191CataractFAERS: 2US FAERS
192CholecystitisFAERS: 2US FAERS
193Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
194Clostridium difficile colitisFAERS: 2US FAERS
195Depressed moodFAERS: 2US FAERS
196Drug administration errorFAERS: 2US FAERS
197Drug prescribing errorFAERS: 2US FAERS
198Ear discomfortFAERS: 2US FAERS
199Ejection Fraction DecreasedFAERS: 2US FAERS
200EosinophiliaFAERS: 2US FAERS
201Epigastric discomfortFAERS: 2US FAERS
202Erythema NodosumFAERS: 2US FAERS
203HypophagiaFAERS: 2US FAERS
204HypoxiaFAERS: 2US FAERS
205Impaired gastric emptyingFAERS: 2US FAERS
206Inappropriate schedule of drug administrationFAERS: 2US FAERS
207Incorrect dose administeredFAERS: 2US FAERS
208KeratitisFAERS: 2US FAERS
209LabyrinthitisFAERS: 2US FAERS
210LeukodermaFAERS: 2US FAERS
211LeukopeniaFAERS: 2SIDER
US FAERS
212Limb injuryFAERS: 2US FAERS
213MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
214MarasmusFAERS: 2US FAERS
215Mental impairmentFAERS: 2US FAERS
216Neutrophil count decreasedFAERS: 2US FAERS
217PallorFAERS: 2US FAERS
218Pancreatic enzymes increasedFAERS: 2US FAERS
219Peripheral arterial occlusive diseaseFAERS: 2US FAERS
220PharyngitisFAERS: 2US FAERS
221Pulmonary arterial hypertensionFAERS: 2US FAERS
222ScabFAERS: 2US FAERS
223ScreamingFAERS: 2US FAERS
224SplenomegalyFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
225Stevens-Johnson SyndromeFAERS: 2US FAERS
226StressFAERS: 2US FAERS
227Tension HeadacheFAERS: 2US FAERS
228ToothacheFAERS: 2US FAERS
229furuncleFAERS: 2US FAERS
230Abdominal rigidityFAERS: 1US FAERS
231Activities of daily living impairedFAERS: 1US FAERS
232Acute Coronary SyndromeFAERS: 1US FAERS
233Adrenal massFAERS: 1US FAERS
234AgitationFAERS: 1US FAERS
235AlkalosisFAERS: 1US FAERS
236Allergic sinusitisFAERS: 1US FAERS
237AphagiaFAERS: 1US FAERS
238AphoniaFAERS: 1US FAERS
239Apparent deathFAERS: 1US FAERS
240ArteritisFAERS: 1US FAERS
241Back disorderFAERS: 1US FAERS
242Benign NeoplasmFAERS: 1US FAERS
243Bladder NeoplasmFAERS: 1US FAERS
244Bladder candidiasisFAERS: 1US FAERS
245Blister ruptureFAERS: 1US FAERS
246Blood blisterFAERS: 1US FAERS
247Blood cholesterol increasedFAERS: 1US FAERS
248Blood glucose abnormalFAERS: 1US FAERS
249Blood potassium increasedFAERS: 1US FAERS
250Blood urea increasedFAERS: 1US FAERS
251Bone infarctionFAERS: 1US FAERS
252Bone marrow reticulin fibrosisFAERS: 1US FAERS
253Bowel movement irregularityFAERS: 1US FAERS
254Brain natriuretic peptide increasedFAERS: 1US FAERS
255Bronchopulmonary AspergillosisFAERS: 1US FAERS
256Capillary Leak SyndromeFAERS: 1US FAERS
257Cardiac dysfunctionFAERS: 1US FAERS
258CardiomegalyFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
259CardiotoxicityFAERS: 1US FAERS
260Cell DeathFAERS: 1US FAERS
261Cervix carcinomaFAERS: 1US FAERS
262ColitisFAERS: 1US FAERS
263Completed SuicideFAERS: 1US FAERS
264Complications of transplant surgeryFAERS: 1US FAERS
265Creatinine renal clearance decreasedFAERS: 1US FAERS
266Creatinine renal clearance increasedFAERS: 1US FAERS
267Cutis LaxaFAERS: 1US FAERS
268CystFAERS: 1US FAERS
269Cytokine stormFAERS: 1US FAERS
270Dental cariesFAERS: 1US FAERS
271Dermatitis acneiformFAERS: 1US FAERS
272DermatitisFAERS: 1SIDER
US FAERS
273Device related infectionFAERS: 1US FAERS
274DiplopiaFAERS: 1US FAERS
275Disease complicationFAERS: 1US FAERS
276DisorientationFAERS: 1US FAERS
277Distributive shockFAERS: 1US FAERS
278Drug dispensing errorFAERS: 1US FAERS
279Drug resistanceFAERS: 1US FAERS
280Dumping SyndromeFAERS: 1US FAERS
281Duodenal UlcerFAERS: 1US FAERS
282DysenteryFAERS: 1US FAERS
283EczemaFAERS: 1US FAERS
284Electrocardiogram abnormalFAERS: 1US FAERS
285EnteritisFAERS: 1US FAERS
286Enterocolitis viralFAERS: 1US FAERS
287EpilepsyFAERS: 1US FAERS
288Erosive DuodenitisFAERS: 1US FAERS
289EscharFAERS: 1US FAERS
290Exposure via partnerFAERS: 1US FAERS
291Extremity necrosisFAERS: 1US FAERS
292Eye irritationFAERS: 1US FAERS
293Facial PainFAERS: 1US FAERS
294Febrile NeutropeniaFAERS: 1SIDER
US FAERS
295Full blood count abnormalFAERS: 1US FAERS
296Full blood count increasedFAERS: 1US FAERS
297Gastric infectionFAERS: 1US FAERS
298GastritisFAERS: 1SIDER
US FAERS
299Gastrointestinal PainFAERS: 1SIDER
US FAERS
300Gastrointestinal hypermotilityFAERS: 1US FAERS
301Gastrointestinal sounds abnormalFAERS: 1US FAERS
302Gastrointestinal toxicityFAERS: 1SIDER
US FAERS
303GlaucomaFAERS: 1US FAERS
304HepatomegalyFAERS: 1US FAERS
305HordeolumFAERS: 1US FAERS
306Humidity intoleranceFAERS: 1US FAERS
307HypercreatininaemiaFAERS: 1US FAERS
308Hypertensive crisisFAERS: 1US FAERS
309HypokinesiaFAERS: 1US FAERS
310HypothyroidismFAERS: 1US FAERS
311IleusFAERS: 1US FAERS
312Inappropriate schedule of product administrationFAERS: 1US FAERS
313IncontinenceFAERS: 1US FAERS
314InfarctionFAERS: 1US FAERS
315Infectious colitisFAERS: 1US FAERS
316Intentional dose omissionFAERS: 1US FAERS
317Intestinal ObstructionFAERS: 1US FAERS
318Intracranial AneurysmFAERS: 1US FAERS
319Invasive Ductal Breast CarcinomaFAERS: 1US FAERS
320Iron deficiencyFAERS: 1US FAERS
321Joint stiffnessFAERS: 1US FAERS
322Large intestine perforationFAERS: 1US FAERS
323LaryngitisFAERS: 1US FAERS
324Lip InfectionFAERS: 1US FAERS
325Loose toothFAERS: 1US FAERS
326Lower respiratory tract infectionFAERS: 1SIDER
US FAERS
327LymphadenopathyFAERS: 1US FAERS
328LymphomaFAERS: 1US FAERS
329MastoiditisFAERS: 1US FAERS
330Mental status changesFAERS: 1US FAERS
331Mood swingsFAERS: 1US FAERS
332Mouth swellingFAERS: 1US FAERS
333Multiple sclerosis relapseFAERS: 1US FAERS
334Musculoskeletal chest painFAERS: 1US FAERS
335Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
336Myasthenia GravisFAERS: 1US FAERS
337Myocardial necrosis marker increasedFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
338MyocarditisFAERS: 1US FAERS
339Nephrotic SyndromeFAERS: 1US FAERS
340NervousnessFAERS: 1US FAERS
341No reaction on previous exposure to drugFAERS: 1US FAERS
342Oropharyngeal candidiasisFAERS: 1US FAERS
343OsteomyelitisFAERS: 1US FAERS
344OverdoseFAERS: 1US FAERS
345OverweightFAERS: 1US FAERS
346Palmar erythemaFAERS: 1US FAERS
347Pancreatic carcinomaFAERS: 1US FAERS
348ParakeratosisFAERS: 1US FAERS
349ParotitisFAERS: 1US FAERS
350Penile blisterFAERS: 1US FAERS
351Peripheral artery stenosisFAERS: 1US FAERS
352PetechiaeFAERS: 1US FAERS
353Physical deconditioningFAERS: 1US FAERS
354PleurisyFAERS: 1US FAERS
355PleuropericarditisFAERS: 1US FAERS
356Poor peripheral circulationFAERS: 1US FAERS
357Poor quality product administeredFAERS: 1US FAERS
358Posterior reversible encephalopathy syndromeFAERS: 1US FAERS
359Primary MyelofibrosisFAERS: 1US FAERS
360Product administration errorFAERS: 1US FAERS
361Product physical consistency issueFAERS: 1US FAERS
362Product physical issueFAERS: 1US FAERS
363Product taste abnormalFAERS: 1US FAERS
364Product used for unknown indicationFAERS: 1US FAERS
365Pulmonary FibrosisFAERS: 1US FAERS
366Reaction to drug excipientsFAERS: 1US FAERS
367Respiratory distressFAERS: 1US FAERS
368Respiratory syncytial virus test positiveFAERS: 1US FAERS
369Respiratory tract congestionFAERS: 1US FAERS
370RestlessnessFAERS: 1US FAERS
371RetchingFAERS: 1US FAERS
372Retinal DetachmentFAERS: 1US FAERS
373RhinalgiaFAERS: 1US FAERS
374RhinitisFAERS: 1US FAERS
375Rotator cuff syndromeFAERS: 1US FAERS
376SarcoidosisFAERS: 1US FAERS
377Sensitivity to weather changeFAERS: 1US FAERS
378Severe invasive streptococcal infectionFAERS: 1US FAERS
379ShockFAERS: 1US FAERS
380Silent myocardial infarctionFAERS: 1US FAERS
381Skin PapillomaFAERS: 1US FAERS
382Skin UlcerFAERS: 1US FAERS
383Skin reactionFAERS: 1US FAERS
384Skin toxicityFAERS: 1US FAERS
385Solar dermatitisFAERS: 1US FAERS
386Spinal StenosisFAERS: 1US FAERS
387Subcutaneous AbscessFAERS: 1US FAERS
388Sudden deathFAERS: 1US FAERS
389SyncopeFAERS: 1US FAERS
390TachycardiaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
391Temporal ArteritisFAERS: 1US FAERS
392Therapeutic response delayedFAERS: 1US FAERS
393Therapeutic response unexpectedFAERS: 1US FAERS
394Therapy changeFAERS: 1US FAERS
395ThrombocytosisFAERS: 1US FAERS
396Tinea crurisFAERS: 1US FAERS
397TinnitusFAERS: 1SIDER
US FAERS
398Tongue discomfortFAERS: 1US FAERS
399Transcription medication errorFAERS: 1US FAERS
400TremorFAERS: 1US FAERS
401Troponin increasedFAERS: 1US FAERS
402Urinary IncontinenceFAERS: 1US FAERS
403Urinary RetentionFAERS: 1US FAERS
404Urinary Tract PainFAERS: 1US FAERS
405Uterine CancerFAERS: 1US FAERS
406UveitisFAERS: 1US FAERS
407Vascular painFAERS: 1US FAERS
408Viral upper respiratory tract infectionFAERS: 1SIDER
US FAERS
409Vulvovaginal painFAERS: 1US FAERS
410West Nile virus test positiveFAERS: 1US FAERS
411Abdominal tendernessSIDER
412AgranulocytosisSIDER
413Anaphylactic shockSIDER
414Atypical pneumoniaSIDER
415Blood amylase increasedSIDER
416Blood and lymphatic system disordersSIDER
417BronchopneumoniaSIDER
418Cytolytic hepatitisSIDER
419Ear and labyrinth disordersSIDER
420Erythema MultiformeSIDER
421Exfoliative rashSIDER
422HepatitisSIDER
423InfestationSIDER
424Lobar PneumoniaSIDER
425Long QT SyndromeSIDER
426MalnutritionSIDER
427MyelosuppressionSIDER
428PrurigoSIDER
429Respiratory tract infection viralSIDER
430Traumatic liver injurySIDER
431nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.